Likarda receives $4M to expand companion animal diabetes researchSeptember 4, 2017Likarda, a regenerative medicine company for companion animals, has received $4 million in Series A funding from Werth Family Investment Associates to back the company's proprietary Kanslet insulin-producing cell clusters, which can be infused into animals with diabetes, allowing veterinarians to offer a minimally invasive and cost-effective answer to pet owners, according to the company. Microencapsulated islets (the insulin-producing cells of the body) are transplanted via injection into the belly of …
SPONSORED CONTENTHelp save more lives with this parvovirus innovationOur Canine Parvovirus Monoclonal Antibody offered a 93% real-world survival rate for puppies afflicted with parvovirus.1 Discover the future of parvo treatment today! + Read More